Gut bacteria swap could ease rare liver disease
NCT ID NCT07477782
First seen Mar 20, 2026 · Last updated Apr 30, 2026 · Updated 3 times
Summary
This study tests whether transplanting healthy donor stool into the gut can improve liver function in people with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD). About 72 adults with stable IBD and elevated liver enzymes will receive either real fecal transplants or a sham procedure, alongside their usual medication. The main goal is to see if the treatment lowers liver enzyme levels and normalizes bilirubin after 48 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (IBD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hepatology Department, Saint Antoine Hospital
Paris, 75012, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.